MAY 2025 Research Alert
This month we added nine new studies to the Best Practice Database, the Best Practices, LLC research repository. These studies spotlight how top biopharma companies design, fund, and execute high-impact Disease Awareness Programs. With a focus on CNS/Neurology, Oncology, and Immunology, the research delivers therapeutic-specific insights into core program elements such as structure, timing, budgeting, effectiveness, advocacy engagement, and digital outreach.
The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.